Top Markets
#1 PulseChain PulseChain +45.01%
#2 Glidr Glidr +20.14%
#3 Fake World Assets Fake World Assets +9.76%
#4 Ergo Ergo +9.25%
#5 eCash eCash +8.85%
#6 DeFi Kingdoms DeFi Kingdoms +8.68%
#7 Ribbita by Virtuals Ribbita by Virtuals +8.32%
#8 Meteora Meteora +8.28%
#9 Verus Coin Verus Coin +7.70%
#10 Cash Cat Cash Cat +7.22%
Coin of the day
PulseChain PulseChain
Instellingen
Taal
DUTCH
Valuta
USD
Thema
LAUNXP Biomedical Co., Ltd LAUNXP Biomedical Co., Ltd

LAUNXP Biomedical Co., Ltd

6876
Rang in aandelen #28462
LAUNXP Biomedical Co. Ltd. specializes in developing innovative pharmaceutical... LAUNXP Biomedical Co. Ltd. specializes in developing innovative pharmaceutical treatments for various types of cancer. Their product line includes therapies designed to combat tumor growth and inhibit cell proliferation, notably utilizing advanced platforms such as virus-like nanoparticles and other nanoparticle-based drug delivery systems. The company was established on September 24, 2015, and its primary corporate operations are based in Taichung, Taiwan.
Aandeelprijs
$0.39430795
Marktkapitalisatie
$27.29M
Verandering (1 dag)
-0.80%
Verandering (1 jaar)
-49.17%
Land
TW
Handel LAUNXP Biomedical Co., Ltd (6876)

Categorie

Healthcare
Dividendrendementgeschiedenis voor LAUNXP Biomedical Co., Ltd (6876)
Het dividendrendement (TTM) van LAUNXP Biomedical Co., Ltd (aandelsymbool: 6876) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van LAUNXP Biomedical Co., Ltd (6876) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten
Bedrijf Dividendrendement Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH